Treatment of central serous chorioretinopathy with topical NSAIDs

Treatment of central serous chorioretinopathy with topical NSAIDs

Sepehr Bahadorani;Kyle Maclean;Kendall Wannamaker;Edward Rickie Chu;Nathan Gresores;Jeong­-Hyeon Sohn;Roberto Diaz­-Rohena;Michael A Singer and
clinical ophthalmology 2019 Vol. 13 pp. 1543-1548
302
sepehr2019treatmentclinical

Abstract

Treatment of central serous chorioretinopathy with topical NSAIDs Sepehr Bahadorani,1 Kyle Maclean,1 Kendall Wannamaker,1 Edward Rickie Chu,1 Nathan Gresores,2 Jeong-Hyeon Sohn,1 Roberto Diaz-Rohena,1 Michael A Singer21Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; 2Medical Center Ophthalmology Associates, San Antonio, TX, USACorrespondence: Michael A SingerMedical Center Ophthalmology Associates, 9157 Huebner Road, San Antonio, TX 78240, USA Tel +1 210 697 2020 Email msinger11

Citation

ID: 5724
Ref Key: sepehr2019treatmentclinical
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
5724
Unique Identifier:
10.2147/OPTH.S202047
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet